Advertisement

Topics

Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements

13:24 EDT 2 Aug 2017 | PharmPro

Molecular Templates, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, announced the completion of its previously announced merger with Threshold Pharmaceuticals, Inc., effective as of August 1, 2017. 
Contributed Author: 
GlobeNewswire
Topics: 

Original Article: Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements

NEXT ARTICLE

More From BioPortfolio on "Molecular Templates Completes Merger with Threshold Pharmaceuticals and Private Placements"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...